Table 1.
Multivariate survival analyses of BLBP expression in two ependymoma trials.
| Survival | Factor | Hazard Ratio (95% C.I.) | p Value |
|---|---|---|---|
| CNS9204 Event-free survival (EFS) | BLBP expression a | 2.08 (1.01–4.26) | 0.04 |
| Location (PF vs. ST) | 7.09 (0.94–53.32) | 0.06 | |
| Resection (Incomplete vs. Complete) | 1.03 (0.51–2.07) | 0.94 | |
| WHO Grade (Grade III vs. Grade II) | 0.81 (0.39–1.66) | 0.55 | |
| CNS9204 Overall Survival (OS) | BLBP expression a | 2.81 (1.2–6.87) | 0.01 |
| Location (PF vs. ST) | 0.00 (0.00 → 10e10 1 × 1011) | 0.97 | |
| Resection (Incomplete vs. Complete | 1.05 (0.47–2.34) | 0.91 | |
| WHO Grade (Grade III vs. Grade II) | 1.35 (0.58–3.13) | 0.97 | |
| CNS9904 Overall Survival (OS) | BLBP expression a | 5.37 (1.70–16.94) | 0.004 |
| Location (PF vs. ST) | 1.84 (0.52–6.47) | 0.34 | |
| Resection (Incomplete vs. Complete) | 1.08 (0.35–3.31) | 0.88 | |
| WHO Grade (Grade III vs. Grade II) | 2.32 (0.51–3.55) | 0.14 |
a positive versus negative. Bold: emphasise the significant values.